Press Releases IRIDEX Corporation

Equities

IRIX

US4626841013

Market Closed - Nasdaq Other stock markets 04:30:01 2024-04-26 pm EDT			5-day change	1st Jan Change
2.87 ^USD	-3.04%		0.00%	+2.14%

Mar. 26	Transcript : IRIDEX Corporation, Q4 2023 Earnings Call, Mar 26, 2024
Mar. 26	Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q4 Revenue $12.5M, vs. Street Est of $14.9M	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Iridex: Q4 Earnings Snapshot	Mar. 26	AQ
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results	Mar. 26	GL
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024	Mar. 20	GL
Iridex Corporation Receives European Patent on MicroPulse Technology	Feb. 06	GL
Iridex Corporation Receives European Patent on MicroPulse Technology	Feb. 06	AQ
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust	Jan. 24	GL
Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma	Jan. 11	GL
Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation	Dec. 28	GL
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation	Nov. 27	GL
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation	Nov. 27	AQ
Iridex: Q3 Earnings Snapshot	Nov. 14	AQ
Iridex Reports Third Quarter 2023 Financial Results and Business Update	Nov. 14	GL
Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023	Nov. 13	GL
IRIDEX : GRANTED IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE - Form 8-K	Nov. 07	PU
Iridex to Report Third Quarter Financial Results on November 14, 2023	23-10-26	GL
IRIDEX : VERIFIED PETITION FOR RELIEF PURSUANT TO 8 DEL. C. § 205 - Form 8-K	23-10-18	PU
Iridex Announces Strategic Review to Unlock Shareholder Value	23-08-29	GL
Iridex: Q2 Earnings Snapshot	23-08-10	AQ
Iridex Reports Second Quarter 2023 Financial Results	23-08-10	GL
Iridex to Report Second Quarter Financial Results on August 10, 2023	23-07-27	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases IRIDEX Corporation

Equities

IRIX

US4626841013

Press Releases

Filters